Sort
130,381 grants matching “hiv”
Clinical Development of Chimp Adenovirus Vectors
$1,337,138Hildegund C. J. Ertl · Wistar Institute · U19 · FY2008 · AI
Impact of Chronic Prenatal THC Exposure on SIV-associated Inflammation and Impairments in Placental and Fetal Development
$1,336,938Jennifer Manuzak · Tulane University Of Louisiana · R01 · FY2025 · DA
Effect of Microbicides on Mucosal HIV Transmission
$1,336,892University Of California Davis · R01 · FY2002 · AI
Neonatal Immunity to novel TF SHIVs
$1,336,670Wilton B Williams · Duke University · R01 · FY2021 · AI
PEDIATRIC ACTG - ACTU
$1,336,540University Of Miami School Of Medicine · U01 · FY2000 · AI
Molecular Analysis Of Retroviral Genes And Their Products
$1,336,456Klaus Strebel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Therapeutic vaccination and PD-1 blockade in treated HIV disease
$1,336,452Steven Grant Deeks · University Of California, San Francisco · U01 · FY2021 · AI
Psychoactive Drug Effects on Brain Arachidonic Acid Signaling and Metabolism
$1,336,314Stanley I Rapoport · National Institute On Aging · ZIA · FY2014 · AG
1) Core Surveillance, 2)HIV INCIDENCE SURVEILLANCE, 3)GEOCODING DATA, 4)MOLECULAR
$1,336,227Susan Scheer · San Francisco Department Of Public Health · U62 · FY2013 · PS
Clinical Studies of Films
$1,335,941Sharon L Hillier · Magee-Women'S Res Inst And Foundation · U19 · FY2015 · AI
LONG-TERM CAPACITY FOR HIV PREVENTION EDUCATION TO YOUTH
$1,335,641Julius Kamera · Hope Educational Foundation · U2G · FY2011 · PS
Delivery of passive immunity against HIV using commensal vaginal Lactobacillus bioengineered to secrete broadly neutralizing domain antibodies
$1,335,502Laurel A. Lagenaur · Osel, Inc. · R44 · FY2014 · AI
Oral pathogenesis and host interactions of KSHV infection (P01 Parent Level)
$1,335,154Timothy M Rose · Seattle Children'S Hospital · P01 · FY2013 · DE
IMPLEMENTATION AND EXPANSION OF HIGH QUALITY HIV PREVENTION, CARE AND TREATMENT
$1,335,000Dr. Meshack Wanjuki · African Medical And Research Foundation · U2G · FY2011 · PS
CoVPN Cross-Protocol Analyses
$1,334,886Peter B. Gilbert · Fred Hutchinson Cancer Research Center · UM1 · FY2022 · AI
Natural Products Discovery and Characterization Through Network Collaborations
$1,334,583Kirk Gustafson · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
SAN FRANCISCO HIV VACCINE CLINICAL TRAILS UNIT
$1,334,433Public Health Foundation Enterprises · U01 · FY2002 · AI
Anti-HIV-1 Composite Cellulose Acetate Phthalate Film
$1,334,391Shibo Jiang · New York Blood Center · U19 · FY2006 · HD
Health, Aging and Dementia in South Africa: A Longitudinal Study (HAALSI)
$1,334,268Lisa F Berkman · Harvard University D/B/A Harvard School Of Public Health · P01 · FY2025 · AG
Development of A Lab-on-a-Chip System for Saliva-Based Diagnostics
$1,334,197John T McDevitt · University Of Texas At Austin · U01 · FY2007 · DE
Immune correlates of protection
$1,334,187Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
HIV/SIV Replication In Vivo
$1,334,187Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
HIVRAD: Structural approaches to vaccine development
$1,333,743Dana-Farber Cancer Institute · P01 · FY2003 · AI
Research Resource for Human Organs and Tissues
$1,333,536Gene C Kopen · National Disease Research Interchange · U42 · FY2016 · OD
Primate Core
$1,333,524Hans-Peter Kiem · University Of Southern California · U19 · FY2023 · HL